Navigation Links
Faulty Dosing Device Prompts Recall of Infants' Tylenol
Date:2/17/2012

By Steven Reinberg
HealthDay Reporter

FRIDAY, Feb. 17 (HealthDay News) -- A potentially faulty dosing system on bottles of Infants' Tylenol has prompted McNeil Consumer Healthcare, a division of Johnson & Johnson, to recall all of the product.

The voluntary recall comes in response to some consumer complaints about the product's so-called SimpleMeasure dosing system, which dispenses measured doses of the medication.

The system includes a dosing syringe that an adult inserts into the cover at the top of the bottle. It's supposed to limit the amount of Tylenol that can be delivered in a single dose, according to the company.

In some cases, inserting the syringe pushed this "flow restrictor" into the bottle.

"Parents can continue to use the product as long as the flow restrictor is in place," Johnson & Johnson spokeswoman Bonnie Jacobs said. "If the flow restrictor does push into the bottle, then they should stop using it and contact us."

According to the company, there have been no adverse events reported due to the problem, "and the risk of a serious adverse medical event is remote."

Jacobs said she didn't know when Infants' Tylenol would be available again. "We're conducting a full review to determine why it's not performing as expected. We are looking at different options," she said.

The recall affects only Infants' Tylenol. Children's Tylenol, which is for use by children 2 years of age and older, remains on the market, Jacobs said.

More information

For more information, visit Johnson & Johnson.

SOURCE: Bonnie Jacobs, spokeswoman, Johnson & Johnson


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Journal Retracts Faulty Chronic Fatigue Study
2. Autism Tests for Preemies May Be Faulty, Study Suggests
3. Faulty off-switch stops children with ADHD from concentrating
4. Drug Targets Faulty Process That Drives Cystic Fibrosis
5. Web Site for Hospital Comparisons Is Faulty: Study
6. Faulty gene stops cell antennae from transmitting
7. Variation in make-up of generic epilepsy drugs can lead to dosing problems
8. FDA Panels to Weigh Dosing Labels for Kids OTC Fever Relievers
9. Lengthening dosing schedule of HPV vaccine may provide effective option for expanding use of vaccine
10. Confusion Over Drug Dosing Common for Seniors
11. Cough Syrup Might Help With Dosing of Breast Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Faulty Dosing Device Prompts Recall of Infants' Tylenol
(Date:1/13/2017)... ... 13, 2017 , ... People with type 2 diabetes know ... easy as checking the nutrition label on foods for grams of sugar. But ... sugar-free, proteins can influence — either positively or negatively — insulin secretion and ...
(Date:1/13/2017)... ... January 13, 2017 , ... A January 10 article ... 2017 according to the publication, with an emphasis on some new techniques that the ... F.A.C.S., who is known more casually to his patients and colleagues as Dr. J, ...
(Date:1/13/2017)... ... , ... With the increasing public preference for chemical-free personal ... alternatives for customers who have grown more conscious about maintaining their health and ... charcoal products, Moody Zook Chief Executive Officer Nate Ginsburg explained their company’s decision ...
(Date:1/13/2017)... ... 2017 , ... An inventor from Virginia Beach, Va., is always on the ... diversify my outfits, so he decided to design something that enhances the look of ... of a belt to allow for quick, easy changing of its look. This not ...
(Date:1/13/2017)... ... , ... "We wanted to create a design for orthodontic appliances that would ... Virginia Beach, Va. , They created a prototype for the patent-pending BRACE FACERS to ... to be customized to suit personal tastes. They can be used to create custom ...
Breaking Medicine News(10 mins):
(Date:1/15/2017)... , January 16, 2017 Der ... Kollagenprodukten für die Regeneration des menschlichen Gewebes, gibt die ... mit sofortiger Wirkung bekannt. ... Bill Allan ... Er bekleidete eine Reihe von Geschäftsführer- und anderen Führungspositionen ...
(Date:1/13/2017)... Eli Lilly and Company (NYSE: ... ) announced today that the U.S. Food and Drug ... new drug application (NDA) for investigational baricitinib, a once-daily ... rheumatoid arthritis (RA). The NDA for baricitinib was submitted ... FDA extended the action date to allow time to ...
(Date:1/13/2017)... , Jan. 13, 2017 Wichita Laser ... cutting-edge laser treatments to Wichita, Kansas ... provides advanced treatments for skin rejuvenation, getting rid of ... lesions and vascular lesions. "Since being in ... in Wichita for laser tattoo ...
Breaking Medicine Technology: